Cargando…
Growth Factor Delivery Using a Collagen Membrane for Bone Tissue Regeneration
The use of biomaterials and bioactive agents has shown promise in bone defect repair, leading to the development of strategies for bone regeneration. Various artificial membranes, especially collagen membranes (CMs) that are widely used for periodontal therapy and provide an extracellular matrix-sim...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216607/ https://www.ncbi.nlm.nih.gov/pubmed/37238679 http://dx.doi.org/10.3390/biom13050809 |
_version_ | 1785048339213975552 |
---|---|
author | Takayama, Tadahiro Imamura, Kentaro Yamano, Seiichi |
author_facet | Takayama, Tadahiro Imamura, Kentaro Yamano, Seiichi |
author_sort | Takayama, Tadahiro |
collection | PubMed |
description | The use of biomaterials and bioactive agents has shown promise in bone defect repair, leading to the development of strategies for bone regeneration. Various artificial membranes, especially collagen membranes (CMs) that are widely used for periodontal therapy and provide an extracellular matrix-simulating environment, play a significant role in promoting bone regeneration. In addition, numerous growth factors (GFs) have been used as clinical applications in regenerative therapy. However, it has been established that the unregulated administration of these factors may not work to their full regenerative potential and could also trigger unfavorable side effects. The utilization of these factors in clinical settings is still restricted due to the lack of effective delivery systems and biomaterial carriers. Hence, considering the efficiency of bone regeneration, both spaces maintained using CMs and GFs can synergistically create successful outcomes in bone tissue engineering. Therefore, recent studies have demonstrated a significant interest in the potential of combining CMs and GFs to effectively promote bone repair. This approach holds great promise and has become a focal point in our research. The purpose of this review is to highlight the role of CMs containing GFs in the regeneration of bone tissue, and to discuss their use in preclinical animal models of regeneration. Additionally, the review addresses potential concerns and suggests future research directions for growth factor therapy in the field of regenerative science. |
format | Online Article Text |
id | pubmed-10216607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102166072023-05-27 Growth Factor Delivery Using a Collagen Membrane for Bone Tissue Regeneration Takayama, Tadahiro Imamura, Kentaro Yamano, Seiichi Biomolecules Review The use of biomaterials and bioactive agents has shown promise in bone defect repair, leading to the development of strategies for bone regeneration. Various artificial membranes, especially collagen membranes (CMs) that are widely used for periodontal therapy and provide an extracellular matrix-simulating environment, play a significant role in promoting bone regeneration. In addition, numerous growth factors (GFs) have been used as clinical applications in regenerative therapy. However, it has been established that the unregulated administration of these factors may not work to their full regenerative potential and could also trigger unfavorable side effects. The utilization of these factors in clinical settings is still restricted due to the lack of effective delivery systems and biomaterial carriers. Hence, considering the efficiency of bone regeneration, both spaces maintained using CMs and GFs can synergistically create successful outcomes in bone tissue engineering. Therefore, recent studies have demonstrated a significant interest in the potential of combining CMs and GFs to effectively promote bone repair. This approach holds great promise and has become a focal point in our research. The purpose of this review is to highlight the role of CMs containing GFs in the regeneration of bone tissue, and to discuss their use in preclinical animal models of regeneration. Additionally, the review addresses potential concerns and suggests future research directions for growth factor therapy in the field of regenerative science. MDPI 2023-05-10 /pmc/articles/PMC10216607/ /pubmed/37238679 http://dx.doi.org/10.3390/biom13050809 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Takayama, Tadahiro Imamura, Kentaro Yamano, Seiichi Growth Factor Delivery Using a Collagen Membrane for Bone Tissue Regeneration |
title | Growth Factor Delivery Using a Collagen Membrane for Bone Tissue Regeneration |
title_full | Growth Factor Delivery Using a Collagen Membrane for Bone Tissue Regeneration |
title_fullStr | Growth Factor Delivery Using a Collagen Membrane for Bone Tissue Regeneration |
title_full_unstemmed | Growth Factor Delivery Using a Collagen Membrane for Bone Tissue Regeneration |
title_short | Growth Factor Delivery Using a Collagen Membrane for Bone Tissue Regeneration |
title_sort | growth factor delivery using a collagen membrane for bone tissue regeneration |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216607/ https://www.ncbi.nlm.nih.gov/pubmed/37238679 http://dx.doi.org/10.3390/biom13050809 |
work_keys_str_mv | AT takayamatadahiro growthfactordeliveryusingacollagenmembraneforbonetissueregeneration AT imamurakentaro growthfactordeliveryusingacollagenmembraneforbonetissueregeneration AT yamanoseiichi growthfactordeliveryusingacollagenmembraneforbonetissueregeneration |